Project overview

Orvium is the first open source and decentralized framework for managing scholarly publications’ life cycles and the associated data. Orvium introduces a disruptive business model into the research publication market through a unique combination of four core technologies: 1. Blockchain and smart contracts; 2. Decentralized storage; 3. Cloud computing; 4. Big data analytics and machine learning.

Using blockchain technology and a decentralized storage approach will allow a public, fully traceable, and trustworthy record of the publication process at a minimal cost. Meanwhile, cloud computing technologies will provide flexibility, global availability and scalability to the platform and services. Finally, big data analytics and machine learning will enable advanced analyses to enhance life cycle automatization, facilitate peer review accuracy (e.g., identify plagiarism), classify papers based on their content and identify emerging trends and topics, among other goals.


Token model

Orvium establishes a transparent, comprehensive and competitive business model which is aligned with its custom ORV token to ensure a continued evolution of the platform white supporting global research. The token will be used as a payment method for each of the phases of a manuscript’s and a journal’s life cycle. Manuscript submission, peer review, payments for copyright licenses, research data sharing, journal management, etc., will generate exchanges of ORV between institutions, authors, peer reviewers, journal owners, readers and any social actor involved.



The Orvium whitepaper is extensive and covers their business model, the token model and the role of the different actors within their platform. It however doesn’t include information about the token sale.



Manuel Martin – Co-Founder, Senior Project Leader & Blockchain Expert
Manuel’s career has been focused on supporting large collaborations through technological innovation. He has led critical data-management, big data and machine-learning initiatives for the largest and most complex scientific instrument ever built (CERN LHC). In addition, he has collaborated with NASA-JPL, Fermilab (U.S. Dept. of Energy) and GSI, among others. He has contributed, as a guest lecturer, to the Executive Program at ESADE Business School, and has advised international companies such as Oracle, BMW, Caixa, Gassco, Eni, UPS.

Antonio Romero – Co-Founder, Technology Solution Architect
Antonio has led several big-data and machine-learning projects for the R&D partnership between CERN and multiple ICT market-leaders. His work – accelerating cutting-edge predictive-maintenance and machine-learning solutions – has fuelled ground-breaking operations and optimizations at the CERN accelerator complex. He has collaborated with other institutions such as Fermilab, GSI and EMBL-EBI.

Roberto Rabasco – Co-Founder, Application and Cloud Technology Expert
Over ten years’ experience working in the private sector for international companies such as Deutsche Telekom, Just Eat or Asos Ltd. Leading, designing and developing high-availability software solutions. Roberto enjoys being part of, as well as leading, successful and productive teams. Decentralized technologies advocate and passionate about developing innovative and creative solutions. He built his own software house in 2016.



Phase 0 – Nebula
2017 Q1 to 2018 Q1
– Idea conception and development:
• Assemble team
• White paper creation
• Incorporate company and legal framework definition
• Stablish collaboration frameworks for partners
• Functional prototype (Web interface, API, smart contracts)
• Marketing campaign
– Token sale:
• Creation and public audit of token sale smart contracts.

Phase 1 – Red Giant
2018 Q2 to Q3
Token sale:
• Launch
• End of sale report publication
• Independent audit of fund disbursement
– Talent finding and recruitment
– Platform:
• User identification
• Paper submission
• Peer review

Phase 2 – Supernova
2018 Q4 to 2019 Q1
• Platform first public release
• Bug bounty program
• Decentralized journals management
• Licenses and Copyrights
– Support for Science and Technology:
• Develop research institution collaboration program
• Develop grant R&D program

Phase 3 – White Dwarf
2019 Q2 to Q3
• Platform second public release
• Patronage
• Funding campaigns
– Support for Science and Technology:
• Establish agreements with universities and research organizations
to incentivize the Orvium publication model
• Launch grant R&D program

Phase 4 – Neuron Star
2019 Q4
• Integrate big data analytics
• Release first fully functional Orvium platform
– Support for Science and Technology:
• Patronage of research lines in collaboration with institutions

Phase 5 – Pulsar
2020 Q1
• Launch Orvium 1.0
• Fine tune the operational efficiency
• Adiabatic and continuous integration of the R&D results to the
Orvium platform
– Market capture and expansion of the business model
– Support for Science and Technology:
• Enhance collaboration programs and frameworks


ICO terms

The token sale will begin in August.

Ticker: ORV
Token type: ERC20
ICO Token Price: 1 ORV = 0.1 USD
Hardcap: 20,000,000 USD
Total Tokens: 379,000,000,000 ANKR
Available for Token Sale: 60%

Token distribution

Orvium token

Use of funds

orvium funds

Community hype

Telegram: 6,806 members
Twitter: 2,498 followers
Facebook: 2,245 likes



  • Orvium’s model ensures that authors and research institutions retain full ownership of copyrights and licenses
  • Orvium highly simplifies the way scientific papers are funded
  • The quality of a paper will not be linked to what journal it is published in anymore


Red flags

  • It will be a challenge for Orvium to become well spread since most scientific papers are government funded and the government is still on the fence about cryptocurrencies.
  • Even though the scientific papers market is sizeable, it is still a very niche market. This will make it harder for Orvium to gain mainstream adoption and maintain value.


Orvium Ratings

Team: 7.3/10

The founders of Orvium are experienced in entrepreneurship. They are very familiar with the scientific paper publishing process. They however have an advisory board of 25 people, which means that they will rely a lot more on them than the average blockchain project.

Token Model: 7/10

The Orvium token model is interesting. Not only is ORV used as payment, it is also used as a stake when submitting or reviewing articles. This creates an incentive for users to hold the token.

Token Distribution: 9/10

Their token distribution is excellent. The team and foundation have a 3 year vesting period and they have a substantial bounty campaign. This will allow for a decentralized distribution.

State of the Project: 5.3/10

Orvium is still pretty far from their mainnet release, which is scheduled for Q1 2020. They do however have a detailed roadmap with easy to track milestones. It will be easy for users and investors to see if they’re on track.

Market: 5/10

Even though the Scientific, Technical and Medical (STM) publishing market is substantial. It is very niche and currently controlled by a few big companies. It will be hard for Orvium to incite authors to use their platform instead of other well-known companies.


ICON score: 6.7/10



At Icon Partners, we think Orvium offers an interesting alternative to real-world issues that come with the current scientific article publishing process. The team and advisory board are really solid and can definitely deliver on the features mentioned in the whitepaper. Therefore, they are still far from the full release of the platform, which is always concerning when looking at ICOs. Finally, the fact that their token model includes a staking aspect will help reduce the velocity of ORV in the long run, increasing the demand for it, pushing its price upwards.

We encourage you to do your own research and come to your own conclusions when investing in an ICO. All the information in this review are either facts or ICON Partners’ opinions and should not be used as investment advice.





P.S. Sign here for our weekly ICO review!

This document is intended for informational purposes only. The views expressed in this document are not, and should not be construed as, investment advice or recommendations.

Privacy Preference Center